Company adds Ian Lennox to the Board of Directors

San Mateo, CA — Thursday, October 3rd, 2024 — Evidation, the market leader in direct-to-participant health research solutions, welcomes Phil Johnson as Chief Commercial Officer. In his new role, Johnson will focus on scaling Evidation’s commercial operations, expanding partnerships, and enhancing the company’s impact on healthcare through its digital platform and community.

"I’m thrilled to be joining Evidation. Evidation’s diverse talent, dynamic community, and innovative technology platform are uniquely positioned to change lives,” said Johnson. “Evidation has built an interactive community of 5 million people, creating an incredible opportunity to directly influence health choices and accelerate drug development. I’m grateful to be part of their mission and eager to get to work."

Johnson brings a wealth of experience in healthcare technology, real world data, and commercial strategy to his role at Evidation. As an executive at Tempus AI, Johnson held senior leadership roles in Clinical Diversity and Innovation, Life Sciences, and Platform Services. At Amazon Web Services, he launched a healthcare and life sciences business unit focused on building strategic partnerships with the fastest growing US healthcare companies.  

“Phil has exceptional experience harnessing health data and platform capabilities to drive meaningful impact in the lives of patients,” said Christine Lemke, CEO and co-founder of Evidation. “Phil has immense talent for building transformative partnerships and high-performing teams. His values-driven leadership approach will serve us well as we continue to grow as a company. We are thrilled to have him on board and look forward to the strides we will make together.”

In addition to Johnson’s appointment, Evidation is pleased to announce that Ian Lennox has joined the company’s Board of Directors. Lennox brings more than three decades of leadership experience in healthcare, life sciences, and enterprise technology. Mr. Lennox is a member of the board of several private companies. As a seasoned board member and executive, Lennox has successfully guided numerous companies through high-growth phases and complex transformations. His deep expertise in scaling organizations will be invaluable as Evidation continues to grow.

About Evidation

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com

Contact

Amy Puliafito

press@evidation.com 

Have questions?

CONTACT US

Company adds Ian Lennox to the Board of Directors

San Mateo, CA — Thursday, October 3rd, 2024 — Evidation, the market leader in direct-to-participant health research solutions, welcomes Phil Johnson as Chief Commercial Officer. In his new role, Johnson will focus on scaling Evidation’s commercial operations, expanding partnerships, and enhancing the company’s impact on healthcare through its digital platform and community.

"I’m thrilled to be joining Evidation. Evidation’s diverse talent, dynamic community, and innovative technology platform are uniquely positioned to change lives,” said Johnson. “Evidation has built an interactive community of 5 million people, creating an incredible opportunity to directly influence health choices and accelerate drug development. I’m grateful to be part of their mission and eager to get to work."

Johnson brings a wealth of experience in healthcare technology, real world data, and commercial strategy to his role at Evidation. As an executive at Tempus AI, Johnson held senior leadership roles in Clinical Diversity and Innovation, Life Sciences, and Platform Services. At Amazon Web Services, he launched a healthcare and life sciences business unit focused on building strategic partnerships with the fastest growing US healthcare companies.  

“Phil has exceptional experience harnessing health data and platform capabilities to drive meaningful impact in the lives of patients,” said Christine Lemke, CEO and co-founder of Evidation. “Phil has immense talent for building transformative partnerships and high-performing teams. His values-driven leadership approach will serve us well as we continue to grow as a company. We are thrilled to have him on board and look forward to the strides we will make together.”

In addition to Johnson’s appointment, Evidation is pleased to announce that Ian Lennox has joined the company’s Board of Directors. Lennox brings more than three decades of leadership experience in healthcare, life sciences, and enterprise technology. Mr. Lennox is a member of the board of several private companies. As a seasoned board member and executive, Lennox has successfully guided numerous companies through high-growth phases and complex transformations. His deep expertise in scaling organizations will be invaluable as Evidation continues to grow.

About Evidation

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com

Contact

Amy Puliafito

press@evidation.com 

Have questions?

CONTACT US

Company adds Ian Lennox to the Board of Directors

San Mateo, CA — Thursday, October 3rd, 2024 — Evidation, the market leader in direct-to-participant health research solutions, welcomes Phil Johnson as Chief Commercial Officer. In his new role, Johnson will focus on scaling Evidation’s commercial operations, expanding partnerships, and enhancing the company’s impact on healthcare through its digital platform and community.

"I’m thrilled to be joining Evidation. Evidation’s diverse talent, dynamic community, and innovative technology platform are uniquely positioned to change lives,” said Johnson. “Evidation has built an interactive community of 5 million people, creating an incredible opportunity to directly influence health choices and accelerate drug development. I’m grateful to be part of their mission and eager to get to work."

Johnson brings a wealth of experience in healthcare technology, real world data, and commercial strategy to his role at Evidation. As an executive at Tempus AI, Johnson held senior leadership roles in Clinical Diversity and Innovation, Life Sciences, and Platform Services. At Amazon Web Services, he launched a healthcare and life sciences business unit focused on building strategic partnerships with the fastest growing US healthcare companies.  

“Phil has exceptional experience harnessing health data and platform capabilities to drive meaningful impact in the lives of patients,” said Christine Lemke, CEO and co-founder of Evidation. “Phil has immense talent for building transformative partnerships and high-performing teams. His values-driven leadership approach will serve us well as we continue to grow as a company. We are thrilled to have him on board and look forward to the strides we will make together.”

In addition to Johnson’s appointment, Evidation is pleased to announce that Ian Lennox has joined the company’s Board of Directors. Lennox brings more than three decades of leadership experience in healthcare, life sciences, and enterprise technology. Mr. Lennox is a member of the board of several private companies. As a seasoned board member and executive, Lennox has successfully guided numerous companies through high-growth phases and complex transformations. His deep expertise in scaling organizations will be invaluable as Evidation continues to grow.

About Evidation

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com

Contact

Amy Puliafito

press@evidation.com 

Have questions?

CONTACT US

Company adds Ian Lennox to the Board of Directors

San Mateo, CA — Thursday, October 3rd, 2024 — Evidation, the market leader in direct-to-participant health research solutions, welcomes Phil Johnson as Chief Commercial Officer. In his new role, Johnson will focus on scaling Evidation’s commercial operations, expanding partnerships, and enhancing the company’s impact on healthcare through its digital platform and community.

"I’m thrilled to be joining Evidation. Evidation’s diverse talent, dynamic community, and innovative technology platform are uniquely positioned to change lives,” said Johnson. “Evidation has built an interactive community of 5 million people, creating an incredible opportunity to directly influence health choices and accelerate drug development. I’m grateful to be part of their mission and eager to get to work."

Johnson brings a wealth of experience in healthcare technology, real world data, and commercial strategy to his role at Evidation. As an executive at Tempus AI, Johnson held senior leadership roles in Clinical Diversity and Innovation, Life Sciences, and Platform Services. At Amazon Web Services, he launched a healthcare and life sciences business unit focused on building strategic partnerships with the fastest growing US healthcare companies.  

“Phil has exceptional experience harnessing health data and platform capabilities to drive meaningful impact in the lives of patients,” said Christine Lemke, CEO and co-founder of Evidation. “Phil has immense talent for building transformative partnerships and high-performing teams. His values-driven leadership approach will serve us well as we continue to grow as a company. We are thrilled to have him on board and look forward to the strides we will make together.”

In addition to Johnson’s appointment, Evidation is pleased to announce that Ian Lennox has joined the company’s Board of Directors. Lennox brings more than three decades of leadership experience in healthcare, life sciences, and enterprise technology. Mr. Lennox is a member of the board of several private companies. As a seasoned board member and executive, Lennox has successfully guided numerous companies through high-growth phases and complex transformations. His deep expertise in scaling organizations will be invaluable as Evidation continues to grow.

About Evidation

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com

Contact

Amy Puliafito

press@evidation.com 

Have questions?

CONTACT US

Company adds Ian Lennox to the Board of Directors

San Mateo, CA — Thursday, October 3rd, 2024 — Evidation, the market leader in direct-to-participant health research solutions, welcomes Phil Johnson as Chief Commercial Officer. In his new role, Johnson will focus on scaling Evidation’s commercial operations, expanding partnerships, and enhancing the company’s impact on healthcare through its digital platform and community.

"I’m thrilled to be joining Evidation. Evidation’s diverse talent, dynamic community, and innovative technology platform are uniquely positioned to change lives,” said Johnson. “Evidation has built an interactive community of 5 million people, creating an incredible opportunity to directly influence health choices and accelerate drug development. I’m grateful to be part of their mission and eager to get to work."

Johnson brings a wealth of experience in healthcare technology, real world data, and commercial strategy to his role at Evidation. As an executive at Tempus AI, Johnson held senior leadership roles in Clinical Diversity and Innovation, Life Sciences, and Platform Services. At Amazon Web Services, he launched a healthcare and life sciences business unit focused on building strategic partnerships with the fastest growing US healthcare companies.  

“Phil has exceptional experience harnessing health data and platform capabilities to drive meaningful impact in the lives of patients,” said Christine Lemke, CEO and co-founder of Evidation. “Phil has immense talent for building transformative partnerships and high-performing teams. His values-driven leadership approach will serve us well as we continue to grow as a company. We are thrilled to have him on board and look forward to the strides we will make together.”

In addition to Johnson’s appointment, Evidation is pleased to announce that Ian Lennox has joined the company’s Board of Directors. Lennox brings more than three decades of leadership experience in healthcare, life sciences, and enterprise technology. Mr. Lennox is a member of the board of several private companies. As a seasoned board member and executive, Lennox has successfully guided numerous companies through high-growth phases and complex transformations. His deep expertise in scaling organizations will be invaluable as Evidation continues to grow.

About Evidation

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com

Contact

Amy Puliafito

press@evidation.com 

Have questions?

CONTACT US

Company adds Ian Lennox to the Board of Directors

San Mateo, CA — Thursday, October 3rd, 2024 — Evidation, the market leader in direct-to-participant health research solutions, welcomes Phil Johnson as Chief Commercial Officer. In his new role, Johnson will focus on scaling Evidation’s commercial operations, expanding partnerships, and enhancing the company’s impact on healthcare through its digital platform and community.

"I’m thrilled to be joining Evidation. Evidation’s diverse talent, dynamic community, and innovative technology platform are uniquely positioned to change lives,” said Johnson. “Evidation has built an interactive community of 5 million people, creating an incredible opportunity to directly influence health choices and accelerate drug development. I’m grateful to be part of their mission and eager to get to work."

Johnson brings a wealth of experience in healthcare technology, real world data, and commercial strategy to his role at Evidation. As an executive at Tempus AI, Johnson held senior leadership roles in Clinical Diversity and Innovation, Life Sciences, and Platform Services. At Amazon Web Services, he launched a healthcare and life sciences business unit focused on building strategic partnerships with the fastest growing US healthcare companies.  

“Phil has exceptional experience harnessing health data and platform capabilities to drive meaningful impact in the lives of patients,” said Christine Lemke, CEO and co-founder of Evidation. “Phil has immense talent for building transformative partnerships and high-performing teams. His values-driven leadership approach will serve us well as we continue to grow as a company. We are thrilled to have him on board and look forward to the strides we will make together.”

In addition to Johnson’s appointment, Evidation is pleased to announce that Ian Lennox has joined the company’s Board of Directors. Lennox brings more than three decades of leadership experience in healthcare, life sciences, and enterprise technology. Mr. Lennox is a member of the board of several private companies. As a seasoned board member and executive, Lennox has successfully guided numerous companies through high-growth phases and complex transformations. His deep expertise in scaling organizations will be invaluable as Evidation continues to grow.

About Evidation

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com

Contact

Amy Puliafito

press@evidation.com 

Have questions?

CONTACT US
Eve: Evidation's brand mark which is a yellow glowing orb

Company adds Ian Lennox to the Board of Directors

San Mateo, CA — Thursday, October 3rd, 2024 — Evidation, the market leader in direct-to-participant health research solutions, welcomes Phil Johnson as Chief Commercial Officer. In his new role, Johnson will focus on scaling Evidation’s commercial operations, expanding partnerships, and enhancing the company’s impact on healthcare through its digital platform and community.

"I’m thrilled to be joining Evidation. Evidation’s diverse talent, dynamic community, and innovative technology platform are uniquely positioned to change lives,” said Johnson. “Evidation has built an interactive community of 5 million people, creating an incredible opportunity to directly influence health choices and accelerate drug development. I’m grateful to be part of their mission and eager to get to work."

Johnson brings a wealth of experience in healthcare technology, real world data, and commercial strategy to his role at Evidation. As an executive at Tempus AI, Johnson held senior leadership roles in Clinical Diversity and Innovation, Life Sciences, and Platform Services. At Amazon Web Services, he launched a healthcare and life sciences business unit focused on building strategic partnerships with the fastest growing US healthcare companies.  

“Phil has exceptional experience harnessing health data and platform capabilities to drive meaningful impact in the lives of patients,” said Christine Lemke, CEO and co-founder of Evidation. “Phil has immense talent for building transformative partnerships and high-performing teams. His values-driven leadership approach will serve us well as we continue to grow as a company. We are thrilled to have him on board and look forward to the strides we will make together.”

In addition to Johnson’s appointment, Evidation is pleased to announce that Ian Lennox has joined the company’s Board of Directors. Lennox brings more than three decades of leadership experience in healthcare, life sciences, and enterprise technology. Mr. Lennox is a member of the board of several private companies. As a seasoned board member and executive, Lennox has successfully guided numerous companies through high-growth phases and complex transformations. His deep expertise in scaling organizations will be invaluable as Evidation continues to grow.

About Evidation

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. Learn more at www.evidation.com

Contact

Amy Puliafito

press@evidation.com 

Related Therapeutic Areas:

No related Therapeutic areas found.
No items found.
Download app